Ultima Thymosin Beta 4 (TB-500) 10mg Ultima Pharmaceuticals

£97.00

TB-500 peptide 10mg by Ultima Pharmaceuticals for laboratory research studies. Investigate thymosin beta-4 mechanisms in cellular migration and tissue repair models.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Ultima Thymosin Beta 4 (TB-500) 10mg Ultima Pharmaceuticals
Ultima Thymosin Beta 4 (TB-500) 10mg Ultima Pharmaceuticals
£97.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Thymosin Beta-4 Research Overview

TB-500 is a synthetic peptide derived from thymosin beta-4, a naturally occurring protein involved in cellular regulation and tissue development. This 43-amino acid sequence peptide serves as a valuable research tool for investigating actin-binding protein pathways and cellular migration mechanisms. Researchers at Stroid UK Shop can examine TB-500’s role in upregulating cell-building proteins and modulating wound healing cascades in controlled laboratory environments.

Cellular Research Applications

Laboratory studies utilize TB-500 to investigate cell migration, proliferation, and differentiation processes in tissue culture models. This peptide demonstrates activity in angiogenesis research, where scientists examine blood vessel formation and endothelial cell behaviour. Academic researchers exploring regenerative medicine pathways often incorporate TB-500 into studies examining cardiac tissue repair mechanisms and inflammatory response modulation. The compound’s interaction with actin polymerization makes it particularly valuable for cytoskeleton research within the broader peptide research category.

Technical Specifications

TB-500 Product Specifications
Parameter Value
Purity Verify with supplier
Molecular Weight 4963.44 g/mol (full TB-4)
CAS Number 77591-33-4
Storage -20°C lyophilised, 2-8°C reconstituted
Manufacturer Ultima Pharmaceuticals
Vial Size 10mg

Researchers studying tissue repair mechanisms often compare TB-500 with other research peptides available in our peptides collection and complementary compounds from the SARMs category.

Research Compliance Statement

This TB-500 10mg product is supplied by Ultima Pharmaceuticals exclusively for in-vitro laboratory research purposes. Not approved for human consumption, therapeutic use, or clinical applications. Researchers must ensure compliance with institutional guidelines and local regulations when conducting peptide studies. Proper laboratory protocols, including appropriate storage conditions and sterile handling procedures, are essential for maintaining compound integrity during experimental procedures.

Related